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ABSTRACT
Summary: Most genes in human, mouse and rat produce more
than one transcript isoform. The Affymetrix Exon Array is a tool for
studying the many processes that regulate RNA production, with
separate probesets measuring RNA levels at known and putative
exons. For insights on how exons levels vary between normal
tissues, we constructed the Affy Exon Tissues track from tissue data
published by Affymetrix. This track reports exon probeset intensities
as log ratios relative to median values across the dataset and renders
them as colored heat maps, to yield quick visual identiﬁcation of
exons with intensities that vary between normal tissues.
Availability: Affy Exon Tissues track is freely available under
the UCSC Genome Browser (http://genome.ucsc.edu/) for human
(hg18), mouse (mm8 and mm9), and rat (rn4).
Contact: cline@biology.ucsc.edu
Supplementary information: Supplementary data are available at
Bioinformatics online.
1 INTRODUCTION
The mammalian transcriptome is complex. By recent estimates,
as many as 94% of human genes undergo alternative splicing
(Wang, et al., 2008). Alternative splicing is consequential as well
as frequent, with effects ranging from altering protein structure to
targeting mRNA for early decay (Hartmann and Valcarcel, 2009).
Furthermore, mammalian genomes contain an abundance of non-
coding RNA genes (Chu and Rana, 2007). In short, to understand
the consequences of transcription, one must look beyond overall
expression levels of known genes.
Affymetrix exon arrays facilitate transcriptome analysis with
probesets that measure RNA abundance for individual exons,
conserved genomic regions, and blocks from syntenic alignments
(see http://www.affymetrix.com/support/technical/technotes/exon
_array_design_technote.pdf). These arrays have offered new
insights on how transcript isoforms may be inﬂuenced by a myriad
of factors including tissue type (Clark et al., 2007), genetic variation
(Kwan et al., 2007; Zhang et al., 2009), differentiation (Yeo et al.,
2007), and disease (Soreq et al., 2008; Thorsen et al., 2008).
∗To whom correspondence should be addressed.
Alternative splicing can arise through normal, regulated
processes; or through abnormalities such as mutation, disease, and
environmental stress (Yeo et al., 2005). Before one can understand
the abnormal conditions, it is valuable to understand the scope of
normal alternative splicing by comparing splicing patterns between
normal tissues. To facilitate this, we have provided the Affy Exon
Tissues tracks in the UCSC Genome Browser (Kuhn et al., 2009),
depicting exon probeset intensities in normal tissues in human,
mouse, and rat.
2 DESCRIPTION
The Affy Exon Tissues track consists of two parts: genomic
coordinates of the exon array probesets; and a heat map indicating
exon probeset intensities in normal tissues, based on data available
from http://www.affymetrix.com/support/technical/sample_data/
exon_array_data.affx. Brieﬂy, normal tissues were assayed
in triplicate, and were analyzed with the Affymetrix Power
Tools software (http://www.affymetrix.com/partners_programs/
programs/developer/tools/powertools.affx) to produce normalized,
background-corrected probeset intensities. For each probeset,
we computed its median intensity for each tissue, and then the
median of these median values. For each experiment, we calculated
the log ratio between the probeset intensity and this median
value. For numeric stability, we added a ﬁxed, background-level
pseudocount to each observation, which also renders probesets
with no expression as constant-valued. The genome browser
renders these log ratios as blue–white–red (shown), green–red,
or yellow–blue heat maps, with the color selection controlled via
the track’s details page. Additional details are provided in the
Supplementary Material.
Figure 1a shows the Affy Exon Tissues track for TPM2 in mm9.
Theconstitutiveexons(thoseincludedinalltranscripts)indicatethat
TPM2 is expressed most strongly in muscle and embryo, with some
expression in ovary. TPM2 has a well-documented pattern of tissue-
dependent splicing, with one isoform produced in skeletal muscle
tissue and another in non-muscle tissue (Gooding and Smith, 2008).
This pattern is apparent in the two mutually-exclusive exons (third
andfourthfromtheleft):oneishighly-expressed(red)inmuscleand
embryo(aheterogeneoustissue),whiletheotherishighly-expressed
in ovary.
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Fig. 1. (a) The Affy Exon Tissues track demonstrates tissue-dependent
splicing of two mutually exclusive exons (third and fourth from the left)
in the mm9 TPM2 locus. Red indicates probesets that are up-regulated
relative to median levels, while blue indicates down-regulated probesets.
The constitutive exons (those included in all transcripts: ﬁrst, second and
ﬁfth from the left) offer perspectives on overall gene expression, and indicate
that the gene is up-regulated (red) in embryo, muscle and ovary.The leftmost
mutually-exclusive exon appears upregulated in embryo and muscle, while
the second appears upregulated in ovary. The remaining two probesets,
which map to no known exons, are rendered mostly white. This indicates no
variation in their expression levels, and suggests that they are not expressed
in these tissues. (b) A probeset was designed for this unannotated region in
mm9 based on more-speculative evidence such as genomic conservation or
ab initio exon prediction. This region shows evidence of up-regulation (red)
in brain, suggesting production of a brain-speciﬁc transcript.
Forcontrast,Figure1bshowsanunannotatedconservedregionon
chromosome 1 in mm9. While it does not overlap with any known
gene, its red (up-regulated) log intensity in brain suggests brain-
speciﬁc expression. This illustrates how this data can offer insights
on regions with no annotation but strong conservation.
3 CONCLUSION
The Affy Exon Tissues track displays exon probeset intensities
in human, mouse, and rat tissues, including breast, cerebellum,
heart, kidney, liver, muscle, pancreas, prostate, spleen, testes,
and thyroid. In contrast to traditional microarray tracks such
as the GNF Expression Atlas (Su et al., 2004), which provide
one measure of overall expression per gene and cannot report
any transcript variation, the Affy Exon Tissues track offers
the ability to compare intensities of neighboring probesets and
observe alternative promoter usage, polyadenylation, and splicing.
Exon probeset intensities are rendered as heat maps to offer rapid
visual identiﬁcation of exons that vary under normal cellular
conditions.
Besides theAffy ExonTissues track, the UCSC Genome Browser
currently hosts the hg18 Sestan Brain exon expression track, which
contrasts exon probeset intensities between sections of the brain
(Johnson et al., 2009). This set of tracks may expand further as
additional datasets become available, offering further insights into
transcript variation in the mammalian genomes.
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